Delta Diagnostics Stock

Delta Diagnostics is a biotech company that creates highly sensitive and selective biosensors using integrated photonics.

Sign up today and learn more about Delta Diagnostics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Delta Diagnostics Stock

Delta Diagnostics was founded in 2018 as a spin-off from TNO – The Netherlands Organisation for Applied Scientific Research. It commercializes the patented biosensor technology that has been developed at the Optics department of TNO. They believe that the availability of their rapid, sensitive and low-cost biosensors and instruments will lead to new point-of-care diagnostic tests that will rely on the accurate concentration measurement of a panel of biomarkers within minutes. Since its founding, the company has grown steadily towards the highly-experienced and well-balanced team this is currently involved. During this time, it has worked hard to perfect its biosensing technology and prepare for the launch of its first product. Delta Diagnostics primarily focusses on the realization of its diagnostic test development platform and will partner with test developers to co-develop specific diagnostic tests.

Funding History

January 2019$71K
December 2019$200K
May 2023$5.3M


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: